HYPERION DEFI, INC. Operating Expenses
HYPERION DEFI, INC. (HYPD) reported Operating Expenses of -$30.65 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- HYPERION DEFI, INC. operating expenses for the quarter ending 2026-06-30 was -$30.65M, a 466.92% decline year-over-year.
- HYPERION DEFI, INC. operating expenses for the quarter ending 2026-03-31 was -$8.49M, a 378.71% decline year-over-year.
- HYPERION DEFI, INC. operating expenses for the quarter ending 2025-12-31 was $39.96M, a 143.98% increase year-over-year.
- HYPERION DEFI, INC. operating expenses for the quarter ending 2025-09-30 was -$4.13M, a 157.29% decline year-over-year.
- HYPERION DEFI, INC. operating expenses for fiscal 2025 was $47.23M, a 5.27% increase from fiscal 2024.
- HYPERION DEFI, INC. operating expenses for fiscal 2024 was $44.87M, a 76.69% increase from fiscal 2023.
- HYPERION DEFI, INC. operating expenses for fiscal 2023 was $25.39M, a 5.64% decline from fiscal 2022.
- HYPERION DEFI, INC. operating expenses for fiscal 2022 was $26.91M, a 5.87% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$30.65M 10-Q · filed 2026-08-13 | -$39.14M 10-Q · filed 2026-08-13 | $820.37K derived: sum of 3 quarters · filed 2026-08-13 | -$3.31M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$8.49M 10-Q · filed 2026-05-15 | $31.47M derived: sum of 2 quarters · filed 2026-05-15 | $27.34M derived: sum of 3 quarters · filed 2026-05-15 | $35.70M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $39.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $35.83M derived: sum of 2 quarters · filed 2026-03-30 | $44.19M derived: sum of 3 quarters · filed 2026-08-13 | $47.23M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | -$4.13M 10-Q · filed 2025-11-14 | $4.23M derived: sum of 2 quarters · filed 2026-08-13 | $7.27M 10-Q · filed 2025-11-14 | $23.65M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $8.35M 10-Q · filed 2026-08-13 | $11.40M 10-Q · filed 2026-08-13 | $27.78M derived: sum of 3 quarters · filed 2026-08-13 | $34.98M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $3.05M 10-Q · filed 2026-05-15 | $19.42M derived: sum of 2 quarters · filed 2026-05-15 | $26.62M derived: sum of 3 quarters · filed 2026-05-15 | $37.84M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $16.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $23.58M derived: sum of 2 quarters · filed 2026-03-30 | $34.80M derived: sum of 3 quarters · filed 2026-03-30 | $44.87M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $7.20M 10-Q · filed 2025-11-14 | $18.42M derived: sum of 2 quarters · filed 2025-11-14 | $28.49M 10-Q · filed 2025-11-14 | $35.96M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $11.22M 10-Q · filed 2025-08-13 | $21.29M 10-Q · filed 2025-08-13 | $28.76M derived: sum of 3 quarters · filed 2025-08-13 | $35.26M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $10.07M 10-Q · filed 2025-05-19 | $10.27M 10-Q · filed 2024-05-15 | $17.54M derived: sum of 2 quarters · filed 2025-05-19 | $24.04M derived: sum of 3 quarters · filed 2025-05-19 | $30.00M derived: sum of 4 quarters · filed 2025-05-19 | |||
| 2023-12-31 | $7.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $13.97M derived: sum of 2 quarters · filed 2025-04-15 | $19.94M derived: sum of 3 quarters · filed 2025-04-15 | $25.39M 10-K · filed 2025-04-15 | $25.41M 10-K · filed 2024-03-18 | |||
| 2023-09-30 | $6.51M 10-Q · filed 2024-11-12 | $6.52M 10-Q · filed 2023-11-13 | $12.47M derived: sum of 2 quarters · filed 2024-11-12 | $17.93M 10-Q · filed 2024-11-12 | $17.94M 10-Q · filed 2023-11-13 | $23.30M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $5.96M 10-Q · filed 2024-08-14 | $11.42M 10-Q · filed 2024-08-14 | $16.79M derived: sum of 3 quarters · filed 2024-08-14 | $24.02M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $5.46M 10-Q · filed 2024-05-15 | $10.83M derived: sum of 2 quarters · filed 2024-05-15 | $18.06M derived: sum of 3 quarters · filed 2024-05-15 | $25.18M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $12.60M derived: sum of 2 quarters · filed 2024-03-18 | $19.72M derived: sum of 3 quarters · filed 2024-03-18 | $26.91M 10-K · filed 2024-03-18 | ||||
| 2022-09-30 | $7.23M 10-Q · filed 2023-11-13 | $14.35M derived: sum of 2 quarters · filed 2023-11-13 | $21.54M 10-Q · filed 2023-11-13 | $28.49M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $7.12M 10-Q · filed 2023-08-11 | $14.31M 10-Q · filed 2023-08-11 | $21.26M derived: sum of 3 quarters · filed 2023-08-11 | $27.18M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $7.19M 10-Q · filed 2023-05-12 | $14.13M derived: sum of 2 quarters · filed 2023-05-12 | $20.06M derived: sum of 3 quarters · filed 2023-05-12 | $26.04M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $6.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $12.87M derived: sum of 2 quarters · filed 2023-03-31 | $18.85M derived: sum of 3 quarters · filed 2023-03-31 | $25.42M 10-K · filed 2023-03-31 | $25.30M 10-K · filed 2022-03-30 | |||
| 2021-09-30 | $5.93M 10-Q · filed 2022-11-14 | $5.91M 10-Q · filed 2021-11-12 | $11.91M derived: sum of 2 quarters · filed 2022-11-14 | $18.47M 10-Q · filed 2022-11-14 | $18.42M 10-Q · filed 2021-11-12 | $23.88M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $5.98M 10-Q · filed 2022-08-11 | $5.96M 10-Q · filed 2021-08-12 | $12.55M 10-Q · filed 2022-08-11 | $12.51M 10-Q · filed 2021-08-12 | $17.96M derived: sum of 3 quarters · filed 2022-08-11 | $23.05M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $6.57M 10-Q · filed 2022-05-13 | $6.55M 10-Q · filed 2021-05-14 | $11.97M derived: sum of 2 quarters · filed 2022-05-13 | $17.07M derived: sum of 3 quarters · filed 2022-05-13 | $22.08M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $10.50M derived: sum of 2 quarters · filed 2022-03-30 | $15.52M derived: sum of 3 quarters · filed 2022-03-30 | $20.99M 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $5.09M 10-Q · filed 2021-11-12 | $10.11M derived: sum of 2 quarters · filed 2021-11-12 | $15.58M 10-Q · filed 2021-11-12 | $20.87M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $5.02M 10-Q · filed 2021-08-12 | $10.49M 10-Q · filed 2021-08-12 | $15.78M derived: sum of 3 quarters · filed 2021-08-12 | $20.47M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $5.47M 10-Q · filed 2021-05-14 | $10.76M derived: sum of 2 quarters · filed 2021-05-14 | $15.45M derived: sum of 3 quarters · filed 2021-05-14 | $20.83M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $5.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $9.98M derived: sum of 2 quarters · filed 2021-03-30 | $15.36M derived: sum of 3 quarters · filed 2021-03-30 | $21.31M 10-K · filed 2021-03-30 | ||||
| 2019-09-30 | $4.69M 10-Q · filed 2020-11-12 | $10.07M derived: sum of 2 quarters · filed 2020-11-12 | $16.02M 10-Q · filed 2020-11-12 | $22.20M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $5.38M 10-Q · filed 2020-08-14 | $11.33M 10-Q · filed 2020-08-14 | $17.51M derived: sum of 3 quarters · filed 2020-08-14 | $21.83M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | $5.95M 10-Q · filed 2020-05-14 | $12.14M derived: sum of 2 quarters · filed 2020-05-14 | $16.46M derived: sum of 3 quarters · filed 2020-05-14 | $19.78M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $6.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $10.50M derived: sum of 2 quarters · filed 2020-03-30 | $13.82M derived: sum of 3 quarters · filed 2020-03-30 | $17.26M 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $4.32M 10-Q · filed 2019-11-13 | $7.64M derived: sum of 2 quarters · filed 2019-11-13 | $11.07M 10-Q · filed 2019-11-13 | $13.24M derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | $3.32M 10-Q · filed 2019-08-13 | $6.75M 10-Q · filed 2019-08-13 | $8.92M derived: sum of 3 quarters · filed 2019-08-13 | $9.80M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | $3.43M 10-Q · filed 2019-05-14 | $5.60M derived: sum of 2 quarters · filed 2019-05-14 | $6.48M derived: sum of 3 quarters · filed 2019-05-14 | $7.46M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-27 | $3.05M derived: sum of 2 quarters · filed 2019-03-27 | $4.03M derived: sum of 3 quarters · filed 2019-03-27 | $5.13M 10-K · filed 2019-03-27 | ||||
| 2017-09-30 | $885.28K 10-Q · filed 2018-11-13 | $1.86M derived: sum of 2 quarters · filed 2018-11-13 | $2.97M 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | $976.88K 10-Q · filed 2018-08-14 | $2.08M 10-Q · filed 2018-08-14 | ||||||
| 2017-03-31 | $1.11M 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | $3.53M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |